Posted in M&A / Deals Obesity’s explosive growth continues as Q1 deals exceed total 2025 value April 16, 2026 BioSpace Commitments in obesity- and diabetes-focused deals reached $22 billion in the first quarter of 2026–already eclipsing last year’s total of $20.3 billion, according to a new J.P. M&A / DealsMetabolic & GLP-1Read full story